Peptic Ulcer Market Projected at $4.91 Billion by 2029 | Strategic Insights and Forecast Data
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
#How Has the Peptic Ulcer Market Size Changed, over the years?#_x000D_
Over the last few years, there has been a steady expansion in the peptic ulcer market size. The market is set to increase from $4.1 billion in 2024 to $4.24 billion in 2025, showing a compound annual growth rate (CAGR) of 3.5%. Factors contributing to this growth over the historical period include the rising incidence of helicobacter pylori infection, increased consumption of nonsteroidal anti-inflammatory drugs (NSAIDs), alterations in lifestyle and food habits, educational campaigns and awareness drives, and an emphasis on managing stress._x000D_
_x000D_
#How Much Will the Peptic Ulcer Market Be Worth in 2029?#_x000D_
The market size for peptic ulcer is slated for consistent expansion in the coming years, anticipating to hit $4.91 billion by 2029 with a compound annual growth rate (CAGR) of 3.7%. This predicted growth can be linked to factors like the rise of novel therapy methods, a growing elderly population, the incorporation of precision medicine, preventative steps and health enhancement, along with ongoing research and clinical trials. Key trends to look out for during the predicted period are the rise of digital health solutions, advancements in treatment strategies, growing incidents of helicobacter pylori infection, increased adoption of diagnostic imaging technologies, and extended use of combination therapies._x000D_
_x000D_
#Download The Free Sample Report Here:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=13221&type=smp_x000D_
_x000D_
#Which is the Largest Company in the Peptic Ulcer Market?#_x000D_
Major companies operating in the peptic ulcer market report are Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., CSL Limited, Boehringer Ingelheim International GmbH, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Zydus Lifesciences, Lupin Limited, Livzon Pharmaceutical Group Inc., Yuhan Corporation, Torrent Pharmaceuticals Ltd., Daewoong Pharmaceutical Co. Ltd., Ilyang Pharmaceutical Co, Jiangsu Carephar Pharmaceutical Co Ltd._x000D_
_x000D_
#What Are the Main Market Drivers in the Peptic Ulcer Industry?#_x000D_
The surge in obesity cases is anticipated to fuel the growth of the peptic ulcer market in the future. Obesity, a health condition identified by excessive body fat accumulation, often leads to an individual having a body mass index (BMI) of 30 or more. It is typically a result of genetic, environmental, and lifestyle influences, like poor nutrition and a lack of physical exercise. Obesity tends to stimulate the production of excessive stomach acid, impairs the protective mucosal lining of the stomach, and escalates the chances of peptic ulcer development. Additionally, being overweight tends to ignite inflammation in the digestive tract, leading to the formation of peptic ulcers. For example, the Centers for Disease Control and Prevention uncovered in September 2024 that from August 2021 to August 2023, the obesity ratio among adults stood at 40.3% with men at 39.2% and women at 41.3%. Thus, the rising obesity figures are fueling the expansion of the peptic ulcer market.
Peptic Ulcer Market Driver: Escalated Smoking Spurs Growth in the Peptic Ulcer Market
_x000D_
_x000D_
#Request For A Customized Report:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=13221&type=smp_x000D_
_x000D_
#How Is the Peptic Ulcer Market Segments Structured?#_x000D_
The peptic ulcer market covered in this report is segmented –_x000D_
_x000D_
1) By Disease Indication: Gastritis, Gastric Ulcer, Duodenal Ulcer, Gastroesophageal Reflux Disease (GERD)_x000D_
2) By Drug Type: Proton Pump Inhibitors (PPI), H2 Antagonists, Antibiotics, Other Drugs_x000D_
3) By Distribution Channel: Hospital Pharmacies, Private Clinics, Drug Store, Retail Pharmacies, E-Commerce_x000D_
_x000D_
Subsegments:_x000D_
1) By Gastritis: Acute Gastritis, Chronic Gastritis_x000D_
2) By Gastric Ulcer: Acute Gastric Ulcer, Chronic Gastric Ulcer_x000D_
3) By Duodenal Ulcer: Acute Duodenal Ulcer, Chronic Duodenal Ulcer_x000D_
4) By Gastroesophageal Reflux Disease (GERD): Non-Erosive GERD, Erosive GERD_x000D_
_x000D_
#What Strategic Trends Are Transforming the Peptic Ulcer Market?#_x000D_
Businesses in the peptic ulcer market are gaining a competitive advantage by creating novel products and solutions, and securing approval from government bodies. Developing new drugs is a key element in handling and curing peptic ulcers, as it helps in managing symptoms, boosting healing processes, averting complications, and addressing the root issue. For example, in April 2023, Akums Drugs and Pharmaceutical Ltd., a company based in India that specializes in pharmaceutical formulations and active pharmaceutical ingredients (APIs), introduced its new formulation, Combikit. This Combikit combines Amoxicillin, Clarithromycin, and Esomeprazole. The Central Drugs Standard Control Organisation (CDSCO) has given approval to this Combikit for the treatment of duodenal ulcers associated with Helicobacter pylori (H. pylori) as well as for the eradication of H. pylori in active or healed-peptic ulcer patients. This particular H. pylori therapy has shown significant effectiveness in diminishing the likelihood of ulcer recurrence, thereby providing substantial benefits to patients. H. pylori infection is significantly common in India, leading to conditions like gastritis and peptic ulcers._x000D_
_x000D_
#Access The Full Report Here:#_x000D_
https://www.thebusinessresearchcompany.com/report/peptic-ulcer-global-market-report_x000D_
_x000D_
#Which Global Regions Offer the Highest Growth in the Peptic Ulcer Market?#_x000D_
North America was the largest region in the peptic ulcer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptic ulcer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_
_x000D_
#Purchase The Full Report Today:#_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13221_x000D_
_x000D_
#This Report Delivers Insight On: #_x000D_
1. How big is the peptic ulcer market, and how is it changing globally?_x000D_
2. Who are the major companies in the peptic ulcer market, and how are they performing?_x000D_
3. What are the key opportunities and risks in the peptic ulcer market right now?_x000D_
4. Which products or customer segments are growing the most in the peptic ulcer market?_x000D_
5. What factors are helping or slowing down the growth of the peptic ulcer market?_x000D_
_x000D_
#About The Business Research Company:#_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 310-496-7795_x000D_
Asia +44 2071930708_x000D_
Europe +44 7882 955267_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
